Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02634619 · ClinicalTrials.gov registry record · NA

A Study of Dorsal Versus Ventral Buccal Mucosa Graft Onlay for Bulbar Urethroplasty

A NA study, sponsored by University of California, San Francisco.

Terminated
Registry status
NA
Development phase
95
Enrollment target

NCT02634619 is a NA study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 95 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02634619, a NA study, was terminated before completion, sponsored by University of California, San Francisco.

TERMINATED
Registry status
NA
Development phase
95 participants
Enrollment target

Study Summary

The investigators propose a randomized non-blinded comparison of dorsal vs. ventral approach for buccal mucosa graft urethroplasty in the bulbar urethra. Buccal mucosa graft is a common method of repairing the strictured urethra. Current evidence suggests the two approaches for placement of the graft are equally successful at correcting the stricture and the two approaches have similar risks of complications. The investigators propose to randomly assign appropriately selected patients to either a dorsally- or ventrally-placed graft. No additional procedures beyond normal care protocol will be required of the patients. Success will be assessed via objective and subjective methods; complications will be tallied in a standardized fashion. Outcomes will be measured at two years.

Interventions

  • PROCEDURE Ventral buccal mucosa onlay urethroplasty
  • PROCEDURE Dorsal buccal mucosa onlay urethroplasty

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2016-06
Est. Completion 2018-11
Phase NA

What the Registry Record Tells You About NCT02634619

The ClinicalTrials.gov registry entry for NCT02634619 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Ventral buccal mucosa onlay urethroplasty is the first listed.

NCT02634619 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02634619 about?

NCT02634619 is a clinical study titled "A Study of Dorsal Versus Ventral Buccal Mucosa Graft Onlay for Bulbar Urethroplasty". The investigators propose a randomized non-blinded comparison of dorsal vs. ventral approach for buccal mucosa graft urethroplasty in the bulbar urethra. Buccal mucosa graft is a common method of repairing the strictured urethra. Current evidence suggests the two approaches for placement of the graf...

What is the current status of trial NCT02634619?

This trial is currently terminated. It is a NA study. The enrollment target is 95 participants. The study started on 2016-06. Estimated completion is 2018-11.

What interventions are being tested in trial NCT02634619?

The interventions under investigation include: Ventral buccal mucosa onlay urethroplasty (PROCEDURE), Dorsal buccal mucosa onlay urethroplasty (PROCEDURE).

Who is sponsoring clinical trial NCT02634619?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.